Skip to main content

Month: June 2025

Reitar Logtech Holdings Limited Initiates Spin-Off of Logistics Automation Unit

Advances MIS Strategy to Strengthen Smart Logistics Ecosystem HONG KONG, June 26, 2025 (GLOBE NEWSWIRE) — Reitar Logtech Holdings Limited (Nasdaq: RITR, “Reitar” or the “Company”) today announced the commencement of a spin-off plan for its logistics automation segment. This follows the Company’s recent acquisition of Jingxing Storage Equipment Engineering (Hong Kong) Limited, which has been integrated as a subsidiary of the group. The spin-off aims to establish the logistics automation unit as an independent capital markets entity focused on smart warehousing, integrated logistics automation hardware/software solutions, and data-driven technologies. This strategic move is designed to unlock the segment’s growth potential and enhance overall shareholder value. As a standalone entity, the spun-off...

Continue reading

Optiva Inc. Announces Results of Annual Meeting

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) — Optiva Inc. (“Optiva” or the “Company“) (TSX:OPT), a leader in powering the telecom industry with cloud-native billing, charging and revenue management software on private and public clouds, today announced that Patrick DiPietro, Lee Matheson, Simon Parmar, Robert Stabile, Barry Symons, and Birgit Troy were elected to the Company’s board of directors (the “Board“) at the Company’s annual meeting of holders of common shares held earlier today (the “Meeting“). In addition, a resolution was carried at the Meeting to re-appoint KPMG LLP as the auditor of the Company and to authorize the Board to fix the auditor’s remuneration. Detailed results of the votes are as follows: 1. Election of DirectorsNominee   Number of Shares...

Continue reading

Jefferson Capital Announces Pricing of Initial Public Offering

MINNEAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off and insolvency consumer accounts, today announced the pricing of its underwritten initial public offering of 10,000,000 shares of common stock at an initial public offering price of $15.00 per share. Jefferson Capital is offering 625,000 shares of common stock, and certain existing stockholders are offering 9,375,000 shares of common stock. In addition, the underwriters of the offering have a 30-day option to purchase from the selling stockholders up to 1,500,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions. Jefferson Capital will not receive any proceeds from the sale of shares by the selling stockholders. Jefferson...

Continue reading

Hi-View Closes Non-Brokered Private Placement for Gross Proceeds of $480,000

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) — HI-VIEW RESOURCES INC. (‘HI-VIEW’ OR THE ‘COMPANY’) (CSE: HVW; OTCQB: HVWRF; FSE: B63) announces that further to its news releases dated May 28th and June 3rd, 2025, the Company has closed its non-brokered private placement consisting of 4,800,000 units (each a “Unit”) at a price of $0.10 per Unit for gross proceeds of $480,000 (the “Private Placement”). Each Unit consists of one common share (each, a “Share“) and one transferrable common share purchase warrant (each, a “Warrant”). Each Warrant entitles the holder to purchase one additional Share of the Company at a price of $0.12 per Share for a period of 36 months from the date of issuance. The Company relied on the exception set out in Section 4.6(2)(b) of CSE Policy 4 – Corporate Governance, Security...

Continue reading

Nevada Zinc Completes Sale of Nevada Mineral Claims

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) — Nevada Zinc Corporation (“Nevada Zinc” or the “Company”) (TSX-V: NZN) is pleased to announce that, further to the its news release dated July 24, 2024, the Company has completed the sale of its interest (the “Transaction”) in its mineral claims located in Eureka County, Nevada (the “Property”) to Minaurum Gold Corp (“Minaurum”) pursuant to the sale and option agreement dated July 24, 2024 (the “Agreement”), as amended. The Property is made up of 203 mineral claims located in Eureka County, Nevada which are comprised of:       (i)     1 patented claim (the “Patented Claim”) and 26 unpatented lode claims, all of which are 100% legally and beneficially owned by the Company’s wholly owned subsidiary, Lone Mountain Zinc Ltd. (collectively, the “Owned Claims”); and       (ii)      176 unpatented...

Continue reading

Eureka Acquisition Corp Announces Revised Contribution to Trust Account and Terms and Conditions in Connection with Proposed Charter Amendment

New York, June 25, 2025 (GLOBE NEWSWIRE) — Eureka Acquisition Corp (the “Company”) (Nasdaq: EURK), a blank check company, today announced that in connection with its previously announced extraordinary general meeting in lieu of an annual general meeting of shareholders to be held on June 30, 2025, at 9:00 a.m., Eastern Time (the “Extraordinary General Meeting”), the Company has revised the contribution to its trust account and the terms and conditions in connection with the proposal to amend the Company’s current Charter (the “Charter Amendment Proposal”). The Charter Amendment Proposal provides that the Company has until July 3, 2025 to complete a business combination, and may elect to extend the period to consummate a business combination up to 12 times, each by an additional one-month extension (the “Monthly Extension”), for...

Continue reading

Acceleware Announces RF XL 2.0

CALGARY, Alberta, June 25, 2025 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, is pleased to announce details of the next generation of RF XL, (“RF XL 2.0”) and a new demonstration plan (the “Demonstration”). “RF XL”, Acceleware’s enhanced oil recovery (“EOR”) technology that uses RF heating to energize oil formations, is a major innovation that could potentially decarbonize heavy oil and oil sands production effectively and efficiently by materially lowering costs compared to other EOR techniques, increasing the recovery factor, and potentially stimulating investment. The...

Continue reading

Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26

Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T. GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, will host an investor webcast on Thursday, June 26, 2025 at 8:30 am E.T. to present topline 24 week data from its IMPACT Phase 2b trial evaluating pemvidutide in the treatment of patients with metabolic dysfunction-associated steatohepatitis (MASH). Conference Call InformationThe Company will host a conference call and webcast at 8:30 am E.T. on June 26, 2025. The call will include remarks from Altimmune management and Dr. Mazen Noureddin, Professor of Medicine at the Houston Methodist Hospital and Co-Chairman of the Board for Summit Clinical...

Continue reading

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased to announce the results of voting at its 2025 annual general meeting of shareholders held on June 25, 2025, in Vancouver, British Columbia (the “Meeting”). All five members of the Company’s board of directors named as nominees in its management information circular dated May 26, 2025 (the “Circular”) were elected as directors: Jeffrey Bacha, Dr. Dennis Brown, Alfredo De Lucrezia, Yevgeniy Meshcherekov and Dr. David Kideckel. In addition, at the Meeting, the shareholders of the Company: (i) approved the re-appointment of Davidson & Company LLP...

Continue reading

Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing   Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia, June 25, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the fiscal year ended March 31, 2025 (“FYE 2025”), and provided an update on fiscal 2026. All figures are stated in Canadian dollars unless otherwise stated. “The recent commercial re-launch of LIKMEZ® (ATI-1501), following new patent coverage through to 2039, marked a major milestone for Appili and our partner, Saptalis Pharmaceuticals, LLC (“Saptalis”)....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.